(Q43856835)

27 November 2017

title

The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients (English)

1 reference

27 November 2017

1 reference

Mizutani K

1

1 reference

27 November 2017

Terasaki P

2

1 reference

27 November 2017

Hamdani E

3

1 reference

27 November 2017

Esquenazi V

4

1 reference

27 November 2017

Rosen A

5

1 reference

27 November 2017

Miller J

6

1 reference

27 November 2017

Ozawa M

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

American Journal of Transplantation

27 November 2017

published in

1 reference

27 November 2017

volume

7

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

1027-1031

1 reference

Predicting kidney graft failure by HLA antibodies: a prospective trial.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01721.X

Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01721.X

Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01721.X

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01721.X

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01721.X

10.1111/J.1600-6143.2006.01721.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference